244 related articles for article (PubMed ID: 34225615)
1. ADMET Profiling in Drug Discovery and Development: Perspectives of In Silico, In Vitro and Integrated Approaches.
Daoud NE; Borah P; Deb PK; Venugopala KN; Hourani W; Alzweiri M; Bardaweel SK; Tiwari V
Curr Drug Metab; 2021; 22(7):503-522. PubMed ID: 34225615
[TBL] [Abstract][Full Text] [Related]
2. A Recent Appraisal of Artificial Intelligence and In Silico ADMET Prediction in the Early Stages of Drug Discovery.
Kumar A; Kini SG; Rathi E
Mini Rev Med Chem; 2021; 21(18):2788-2800. PubMed ID: 33797376
[TBL] [Abstract][Full Text] [Related]
3. Open access in silico tools to predict the ADMET profiling of drug candidates.
Kar S; Leszczynski J
Expert Opin Drug Discov; 2020 Dec; 15(12):1473-1487. PubMed ID: 32735147
[TBL] [Abstract][Full Text] [Related]
4. Modeling ADMET.
Ghosh J; Lawless MS; Waldman M; Gombar V; Fraczkiewicz R
Methods Mol Biol; 2016; 1425():63-83. PubMed ID: 27311462
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in physicochemical and ADMET profiling in drug discovery.
Wang J; Skolnik S
Chem Biodivers; 2009 Nov; 6(11):1887-99. PubMed ID: 19937823
[TBL] [Abstract][Full Text] [Related]
6. Machine Learning for In Silico ADMET Prediction.
Jia L; Gao H
Methods Mol Biol; 2022; 2390():447-460. PubMed ID: 34731482
[TBL] [Abstract][Full Text] [Related]
7. Application of Advanced Technologies in Natural Product Research: A Review with Special Emphasis on ADMET Profiling.
Borah P; Hazarika S; Deka S; Venugopala KN; Nair AB; Attimarad M; Sreeharsha N; Mailavaram RP
Curr Drug Metab; 2020; 21(10):751-767. PubMed ID: 32664837
[TBL] [Abstract][Full Text] [Related]
8. Beyond profiling: using ADMET models to guide decisions.
Segall M; Champness E; Obrezanova O; Leeding C
Chem Biodivers; 2009 Nov; 6(11):2144-51. PubMed ID: 19937845
[TBL] [Abstract][Full Text] [Related]
9. Improving compound quality through in vitro and in silico physicochemical profiling.
van de Waterbeemd H
Chem Biodivers; 2009 Nov; 6(11):1760-6. PubMed ID: 19937820
[TBL] [Abstract][Full Text] [Related]
10. In Silico Meets In Vitro Techniques in ADMET Profiling of Drug Discovery (Part I).
Kar S; Chatterjee S
Curr Drug Metab; 2020; 21(10):745. PubMed ID: 33327905
[No Abstract] [Full Text] [Related]
11. Computational Approaches in Preclinical Studies on Drug Discovery and Development.
Wu F; Zhou Y; Li L; Shen X; Chen G; Wang X; Liang X; Tan M; Huang Z
Front Chem; 2020; 8():726. PubMed ID: 33062633
[TBL] [Abstract][Full Text] [Related]
12. The importance of employing computational resources for the automation of drug discovery.
Rosales-Hernández MC; Correa-Basurto J
Expert Opin Drug Discov; 2015 Mar; 10(3):213-9. PubMed ID: 25682781
[TBL] [Abstract][Full Text] [Related]
13. In silico tools used for compound selection during target-based drug discovery and development.
Caldwell GW
Expert Opin Drug Discov; 2015; 10(8):901-23. PubMed ID: 25952011
[TBL] [Abstract][Full Text] [Related]
14. Role of ADME characteristics in drug discovery and their in silico evaluation: in silico screening of chemicals for their metabolic stability.
Gombar VK; Silver IS; Zhao Z
Curr Top Med Chem; 2003; 3(11):1205-25. PubMed ID: 12769701
[TBL] [Abstract][Full Text] [Related]
15. Toward in silico structure-based ADMET prediction in drug discovery.
Moroy G; Martiny VY; Vayer P; Villoutreix BO; Miteva MA
Drug Discov Today; 2012 Jan; 17(1-2):44-55. PubMed ID: 22056716
[TBL] [Abstract][Full Text] [Related]
16. Integration of in silico and in vitro tools for scaffold optimization during drug discovery: predicting P-glycoprotein efflux.
Desai PV; Sawada GA; Watson IA; Raub TJ
Mol Pharm; 2013 Apr; 10(4):1249-61. PubMed ID: 23363443
[TBL] [Abstract][Full Text] [Related]
17. In Silico Meets In
Kar S; Chatterjee S
Curr Drug Metab; 2021; 22(7):502. PubMed ID: 34525918
[No Abstract] [Full Text] [Related]
18. Prediction of ADMET Properties.
Norinder U; Bergström CA
ChemMedChem; 2006 Sep; 1(9):920-37. PubMed ID: 16952133
[TBL] [Abstract][Full Text] [Related]
19. QM Calculations in ADMET Prediction.
Pozzan A
Methods Mol Biol; 2020; 2114():285-305. PubMed ID: 32016900
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in silico assessment of the developability of a designed monoclonal antibody library.
Wolf Pérez AM; Sormanni P; Andersen JS; Sakhnini LI; Rodriguez-Leon I; Bjelke JR; Gajhede AJ; De Maria L; Otzen DE; Vendruscolo M; Lorenzen N
MAbs; 2019; 11(2):388-400. PubMed ID: 30523762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
